During the past decade, Ormond Medical Arts Pharmaceutical Research Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 17 clinical trials were completed, i.e. on average, 89.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ormond Medical Arts Pharmaceutical Research Center" #1 sponsor was "Pfizer" with 8 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ormond Medical Arts Pharmaceutical Research Center" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Integrium" with 2 trials as a collaborator and "Novum Pharmaceutical Research Services" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ormond Medical Arts Pharmaceutical Research Center" are "Migraine, With or Without Aura" (3 trials), "Chronic Pain" (2 trials), "Hot Flashes" (2 trials), "Hypertension" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Ormond Medical Arts Pharmaceutical Research Center" in a lesser frequency.

Most popular intervention types in "Ormond Medical Arts Pharmaceutical Research Center" are "Drug" (26 trials), "Biological" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Rimegepant" (4 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials) and "WC3011 Estradiol Vaginal Cream" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ormond Medical Arts Pharmaceutical Research Center" are 24 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Ormond Medical Arts Pharmaceutical Research Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Ormond Medical Arts Pharmaceutical Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ormond Medical Arts Pharmaceutical Research Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".